Hereditary Angioedema
📧 Sign up to get email alerts when something new happens for Hereditary Angioedema.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-03-28FDA Approved: KALBITOR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Kalbitor (ecallantide) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2013-08-30FDA Approved: FIRAZYR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Firazyr (icatibant acetate) from Takeda Pharmaceuticals America, Inc., resulting in changes to t…
-
FDA approval · 2013-04-10FDA Approved: KALBITOR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Kalbitor (ecallantide) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2013-01-28FDA Approved: FIRAZYR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approves a supplemental application for FIRAZYR (icatibant acetate) from Takeda Pharmaceuticals America, expanding/updating its appr…
-
FDA approval · 2012-11-28FDA Approved: FIRAZYR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for FIRAZYR (icatibant acetate) by Takeda Pharmaceuticals America, Inc., approving a supplement …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-04-24FDA Approved: KALBITOR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Kalbitor (ecallantide) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2012-03-19FDA Approved: DANAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for danazol from Teva Pharmaceuticals USA, Inc. The approval updates the drug's labeling and/or indi…
-
FDA approval · 2011-08-25FDA Approved: FIRAZYR — Original Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved Firazyr (icatibant acetate) from Takeda Pharmaceuticals America, Inc. for the acute treatment of hereditary angioedema atta…
-
FDA approval · 2011-08-17FDA Approved: KALBITOR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Kalbitor (ecallantide) from Takeda Pharmaceuticals America, Inc. The action updates the product'…
-
FDA approval · 2011-04-05FDA Approved: KALBITOR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Kalbitor (ecallantide) from Takeda Pharmaceuticals America, Inc. Kalbitor treats hereditary …
-
FDA approval · 2009-12-01FDA Approved: KALBITOR — Original Application (Takeda Pharmaceuticals America, Inc.)
FDA approved Kalbitor (ecallantide) through an Original Application, confirming its approval for treatment of hereditary angioedema.
-
FDA approval · 2007-04-19FDA Approved: DANAZOL — Original Application (Lannett Company, Inc.)
FDA approved the original application for the generic Danazol (DANAZOL) from Lannett Company, Inc. Indications include endometriosis, heredi…